Deqing Pei, MS



I joined the department of biostatistics at St.Jude in 2001 after graduated from Iowa State University. I love working at St. Jude, which helps me to see a direct connection between my number-crunching career and the life-saving work at St. Jude. And it makes me feel so special and privileged to be involved in childhood cancer research to save more children. The major focus of my work has been in the area of acute lymphocytic leukemia, pathology and bioinformatics. I participate in the programming, analysis of data, graphical presentation of results and reporting of results with interpretations and explanations of statistical techniques used and valid inference.

Education, Training, Certification
1990  BS, Agronomy  -  Beijing Agriculture University
2000  MS, Genetics  -  Iowa State University
2001  MS, Statistics  -  Iowa State University

Selected Publications
Pui C-H, Pei D, Sandlund JT, Campana D, Ribeiro RC, Razzouk BI, Rubnitz JE, Howard SC, Hijiya N, Jeha S, Cheng C, Downing JR, Relling MV, Evans WE. Risk of Adverse Events after Completion of Therapy for Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 31: 7936-7941, 2005

Pui C-H, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson M, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE. Improved Outcome for Children with Acute Lymphoblastic Leukemia: Results of Total Therapy Study XIIIB at St. Jude Children’s Research Hospital. Blood 104(9):2690-6, 2004.

Cheng C, Pounds S, Boyett JM, Pei D, Kuo ML, Roussel MF. Statistical significance threshold criteria for analysis of microarray gene expression data. Statistical Applications in Genetics and Molecular Biology 3(1):36, 2004

Hak L, Relling MV, Cheng C, Pei D, Wang B, Sandlund JT, Rubnitz J, Pui C-H. Anti-Asparaginase Antibodies and Asparagine Depletion related to thrombosis in children with newly diagnosed ALL. Leukemia 18:1072-7, 2004.

Edick MJ, Cheng C, Yang W, Cheok ML, Wilkinson M, Pei D, Evans WE, Kun LE, Pui C-H, Relling MV. Lymphoid gene expression as a predictor of risk of secondary brain tumors. Genes, Chromosomes & Cancer 42(2):107-16, 2004.

Holleman A, Cheok MH, den Boer ML, Yang W, Veerman AJP, Kazemier KM, Pei D, Cheng C, Pui C-H, Relling MV, Janka-Schaub GE, Pieters R, Evans WE. Gene expression patterns in drug resistance acute lymphoblastic leukemia and treatment response. The New England Journal of Medicine 351:533-42, 2004.

Sawyer MB, Innocenti F, Das S, Cheng C, Ramirez J, Pantle FH, Wright C, Pei D, Boyett JM, Cook JE, Ratain MJ. A pharmacogenetic study of UDP-glucuronosyltransferase 2B7 in patients receiving morphine. Clinical Pharmacology and Therapeutics 73:566-74, 2003.

Pui C-H, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC, Rubnitz JE, Razzouk BI, Hudson M, Cheng C, Raimondi SC, Behm FG, Downing J, Relling MV, Evans WE. Recent improvements in therapy for Acute Lymphoblastic extend to black children. The Journal of the American Medical Association 290:2001-2007, 2003.

Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui C-H, Relling MV. Homocystein, Pharmacogenetics, and Neurotoxicity in Children with Leukemia. Journal of Clinical Oncology 21: 3084-3091, 2003.

Kuo ML, Duncavage EJ, Mathew R, Besten WD, Pei D, Naeve D, Randle DH, Dang JJ, Cheng C, Sherr CJ, Roussel MF. Arf induces p53-dependent and –independent antiproliferative genes. Cancer Research 63:1046-53, 2003.